Hanmi Obesity Pipeline
Scope
Date
~
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab, Yuhan to co-work for obesity treatment
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor wins $31 mn order HBM equipment for SK Hynix
South Korean chip equipment company Hanmi Semiconductor Co. said on Friday that it has secured a 41.5 billion won ($31.4 million) deal with SK Hynix...
Sep 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Voronoi to strengthen AI-driven open innovation
South Korea’s biotechnology startup Voronoi Inc. announced on Monday that it is intensifying its artificial intelligence (AI)-driven new drug ...
Aug 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Korean stock market
MSCI Korea Index adds EcoPro, Hanwha Ocean, drops Emart
Four stocks, including EcoPro Co., have been added to the Morgan Stanley Capital International (MSCI) Korea Index, and two have been removed.MSCI, a...
Aug 11, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor opens new bonder factory
South Korean chip equipment company Hanmi Semiconductor Co. said on Wednesday it has opened a new factory to boost the production of dual TC bonders...
Aug 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...
Jun 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis to enhance biosimilar presence with Epysqli
FRANKFURT – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is looking to gain ground in the ra...
Jun 12, 2023 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor sets up local corporation in Vietnam
South Korean chip equipment maker Hanmi Semiconductor Co. said on Wednesday that it has set up a local subsidiary, Hanmi Vietnam, in the Bac Ninh re...
May 31, 2023 (Gmt+09:00)
-
Machinery
Hanmi Semiconductor named world’s top 10 chip equipment maker
South Korean chip equipment maker Hanmi Semiconductor Co. on Thursday said it made the world’s top 10 in the rankings of TechInsights, a globa...
May 19, 2023 (Gmt+09:00)
-
Hydrogen economy
SK Energy opens S.Korea's first hydrogen charging station for large trucks
SK Energy is the first company in South Korea to launch a station for charging large hydrogen-powered trucks. The company on Sunday said it held a c...
Apr 10, 2023 (Gmt+09:00)
-
Korean chipmakers
Korea to raise young chip engineers for Samsung, SK Hynix
South Korea plans to nurture more youths specialized in semiconductors at high schools to ease the worsening shortage of high-skilled workers at d...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharmaceutical reports record-high revenue in 2022
South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Upcoming IPOs
S.Korean companies in renewed push for Kosdaq listings
South Korean companies are making renewed pushes to go public this year even at the expense of reduced IPO values.Zaram Technology Inc., a chip desi...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Medicox, Oramed sign MOU to enlist more institutional investors
South Korea's biomedicine firm Medicox Co. said on Monday that it had signed a strategic memorandum of understanding (MOU) with Oramed Pharmaceutica...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
SillaJen shares jump as exchange maintains listing, allows resumed trade
Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...
Oct 13, 2022 (Gmt+09:00)
-
Foreign exchange
Falling won yet to cool Koreans’ fever for overseas travel
The South Korean won has continued its decline to hit lows not seen since the 2008-09 global financial crisis on sustained concerns of an economic d...
Sep 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Steel
Steelmaker Husteel's operating profit skyrockets 579% in first half
Shares of Husteel, the only public company within the golf course giant Shinan Group, have doubled in price in the last three months. Industry ...
Sep 08, 2022 (Gmt+09:00)
-
North Korea
Ukraine war gives North Korea reasons to draw closer to Russia
SEOUL—Russia’s invasion of Ukraine has created an opportunity for North Korea, which has strengthened its ties with Moscow and beco...
Sep 02, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand